Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Northern Trust Co. stock logo
NTRS
Northern Trust
$84.62
+1.3%
$83.99
$62.44
$89.25
$17.31B1.131.35 million shs927,129 shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.81
+0.4%
$26.88
$25.20
$40.37
$157.48B0.6341.90 million shs60.57 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Northern Trust Co. stock logo
NTRS
Northern Trust
0.00%+1.49%-2.25%+5.27%+15.60%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+9.49%+4.35%+3.27%-27.67%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Northern Trust Co. stock logo
NTRS
Northern Trust
3.1377 of 5 stars
1.15.03.30.03.42.51.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9934 of 5 stars
4.23.04.24.83.71.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Northern Trust Co. stock logo
NTRS
Northern Trust
2.10
Hold$84.920.35% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.0029.45% Upside

Current Analyst Ratings

Latest PFE and NTRS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$28.00 ➝ $29.00
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$33.00 ➝ $36.00
4/18/2024
Northern Trust Co. stock logo
NTRS
Northern Trust
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$101.00 ➝ $103.00
4/17/2024
Northern Trust Co. stock logo
NTRS
Northern Trust
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$93.00 ➝ $101.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/4/2024
Northern Trust Co. stock logo
NTRS
Northern Trust
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$86.00 ➝ $87.00
4/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
3/22/2024
Pfizer Inc. stock logo
PFE
Pfizer
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
3/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
2/23/2024
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$36.00
(Data available from 5/5/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Northern Trust Co. stock logo
NTRS
Northern Trust
$12.12B1.43$9.60 per share8.81$54.83 per share1.54
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.69$2.98 per share9.34$15.81 per share1.76

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Northern Trust Co. stock logo
NTRS
Northern Trust
$1.11B$4.5318.6811.951.217.59%12.57%0.91%7/17/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B-$0.06N/A10.111.19-0.56%8.58%3.70%8/6/2024 (Estimated)

Latest PFE and NTRS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024Q1 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.56$0.82+$0.26$1.09$13.87 billion$14.88 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Northern Trust Co. stock logo
NTRS
Northern Trust
$3.003.55%+2.33%66.23%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.04%+2.57%N/A 15 Years

Latest PFE and NTRS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Northern Trust Co. stock logo
NTRS
Northern Trust
Quarterly$0.753.69%6/7/20246/7/20247/1/2024
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Northern Trust Co. stock logo
NTRS
Northern Trust
0.61
0.71
0.71
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Northern Trust Co. stock logo
NTRS
Northern Trust
83.19%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Northern Trust Co. stock logo
NTRS
Northern Trust
0.64%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Northern Trust Co. stock logo
NTRS
Northern Trust
23,100204.59 million203.28 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

PFE and NTRS Headlines

SourceHeadline
ARS Wealth Advisors Group LLC Lowers Stock Holdings in Pfizer Inc. (NYSE:PFE)ARS Wealth Advisors Group LLC Lowers Stock Holdings in Pfizer Inc. (NYSE:PFE)
marketbeat.com - May 5 at 3:47 PM
3 No-Brainer Stocks to Buy in May3 No-Brainer Stocks to Buy in May
fool.com - May 5 at 6:55 AM
Pfizer (NYSE:PFE)  Shares Down 0.3% Pfizer (NYSE:PFE) Shares Down 0.3%
americanbankingnews.com - May 5 at 4:38 AM
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming DividendDo These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
finance.yahoo.com - May 4 at 6:18 PM
Ellerson Group Inc. ADV Buys 119,262 Shares of Pfizer Inc. (NYSE:PFE)Ellerson Group Inc. ADV Buys 119,262 Shares of Pfizer Inc. (NYSE:PFE)
marketbeat.com - May 4 at 3:55 PM
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
fool.com - May 4 at 5:17 AM
FY2025 Earnings Estimate for Pfizer Inc. Issued By Leerink Partnrs (NYSE:PFE)FY2025 Earnings Estimate for Pfizer Inc. Issued By Leerink Partnrs (NYSE:PFE)
americanbankingnews.com - May 4 at 4:38 AM
Pfizer Inc. (PFE) Q1 2024 Earnings Call TranscriptPfizer Inc. (PFE) Q1 2024 Earnings Call Transcript
msn.com - May 3 at 11:19 PM
Buy Rating Affirmed for Pfizer Amid Strong Q1 Performance and Strategic Cost SavingsBuy Rating Affirmed for Pfizer Amid Strong Q1 Performance and Strategic Cost Savings
markets.businessinsider.com - May 3 at 11:19 PM
Pfizer (NYSE:PFE) Stock Price Down 0.3%Pfizer (NYSE:PFE) Stock Price Down 0.3%
marketbeat.com - May 3 at 9:55 PM
Amgens peek at its GLP-1 drug trial results heightens competition in obesity marketAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
finance.yahoo.com - May 3 at 6:19 PM
Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?
stocknews.com - May 3 at 1:17 PM
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With ExpectationsPfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
msn.com - May 3 at 1:16 PM
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJs New Plan to Resolve Talc ClaimsPharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
finance.yahoo.com - May 3 at 1:16 PM
Vanguard Health Care Funds Strategic Moves in Q1 2024: A Focus on Pfizer IncVanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
finance.yahoo.com - May 3 at 1:16 PM
Pfizer Inc. (NYSE:PFE) to Post FY2025 Earnings of $2.93 Per Share, Leerink Partnrs ForecastsPfizer Inc. (NYSE:PFE) to Post FY2025 Earnings of $2.93 Per Share, Leerink Partnrs Forecasts
marketbeat.com - May 3 at 12:53 PM
Heres Why Pfizer (PFE) is a Strong Momentum StockHere's Why Pfizer (PFE) is a Strong Momentum Stock
zacks.com - May 3 at 10:56 AM
Great Valley Advisor Group Inc. Trims Stake in Pfizer Inc. (NYSE:PFE)Great Valley Advisor Group Inc. Trims Stake in Pfizer Inc. (NYSE:PFE)
marketbeat.com - May 3 at 9:14 AM
NHS to provide Pfizer’s Voxelotor to treat sickle cell diseaseNHS to provide Pfizer’s Voxelotor to treat sickle cell disease
pharmaceutical-technology.com - May 3 at 8:16 AM
Q1 2024 Cardiff Oncology Inc Earnings CallQ1 2024 Cardiff Oncology Inc Earnings Call
finance.yahoo.com - May 3 at 8:16 AM
3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market
investorplace.com - May 3 at 7:00 AM
Pfizer (NYSE:PFE) Shares Up 1.8% on Earnings BeatPfizer (NYSE:PFE) Shares Up 1.8% on Earnings Beat
americanbankingnews.com - May 3 at 2:12 AM
Fifth Third Bancorp Reduces Position in Pfizer Inc. (NYSE:PFE)Fifth Third Bancorp Reduces Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - May 3 at 12:41 AM
Pfizer Q1 earnings: non-Covid product sales help post revenues of $14.9 billion despite Comirnaty, Paxlovid declinePfizer Q1 earnings: non-Covid product sales help post revenues of $14.9 billion despite Comirnaty, Paxlovid decline
msn.com - May 2 at 9:58 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Northern Trust logo

Northern Trust

NASDAQ:NTRS
Northern Trust Corporation, a financial holding company, provides wealth management, asset servicing, asset management, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Asset Servicing and Wealth Management. The Asset Servicing segment offers asset servicing and related services, including custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment serves corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking services. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately held businesses. The company also provides asset management services, such as active and passive equity; active and passive fixed income; cash management; muti-asset and alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay and other risk management services. Northern Trust Corporation was founded in 1889 and is headquartered in Chicago, Illinois.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.